Chemed Corp (CHE) reports robust growth in VITAS admissions and revenue, while Roto-Rooter faces headwinds from weather disruptions and increased marketing costs.

Q1 2026 Management view "VITAS performance during the quarter exceeded even the high end of our expectations," said (CEO, ...

Most business owners obsess over gross revenue, but it's net revenue that reveals whether you're actually building something ...

The pharmaceutical revenue management function sits atop an enormous pool of value and an equally enormous pool of risk.

Operator: Greetings, and welcome to the Gentherm First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a ...

Sterling Infrastructure (STRL) surges on AI data center demand and analyst upgrades while Graco (GGG) falls after missing Q1 ...

Brinker (EAT) downgraded to sell as same-store sales slow, margins lag, and leverage rises - see key risks to earnings and ...

Weeks before Cursor agreed to a $60 billion potential takeover from SpaceX, the hot AI coding startup set out to raise ...

Medical Segment Milestone -- Announced FDA 510 (k) submission for ThermAffyx, with expected revenue generation later in 2026 ...

Intel came into Thursday with a lot to prove and left with a much louder number set. The chipmaker posted first-quarter ...

The first quarter 2026 gross margin, excluding Medicare Cap, was 22.9%, a 71-basis point decline from the same period of 2025 ...

Q1 2026 earnings call: margins, incentives, build-to-order shift, 2026 guidance reaffirmed, and $2.1B buyback capacity—read now.